Deriv executive director of the Cyprus office, Geo Nicolaidis, is leaving the company after more than four years with the retail FX and CFDs broker.Nicolaidis recently launched TrailBit.io, a Bitcoin blockchain analytics venture focused on forensic and research tools for individuals and organizations. The company publishes research findings through TrailBit Labs while offering analytics tools through its platform.Deriv Executive Builds AI Automation SystemsDuring his time at Deriv, Nicolaidis held several senior positions, including Executive Director of the Cyprus office, Senior Product Manager, and most recently Technical Product Owner for AI Automations.In the executive role, he oversaw the expansion of the Cyprus operation and helped establish hiring processes and operational infrastructure. He said the office earned Great Place to Work certification for three consecutive years as well as Investors in People Platinum accreditation during his tenure.Alongside his management responsibilities, Nicolaidis worked on projects tied to trading platforms, affiliate systems, and developer APIs. In his latest role, he focused on AI automation tools across multiple departments. According to his LinkedIn profile, the work involved workflow automation, prompt engineering, API integration, and internal operational tools.XAmplifier Role Focuses on US SaaS BuildBefore joining Deriv, Nicolaidis spent nearly a year at FXGT as Senior Product Manager, where he worked on the redesign of client and partner trading platforms.Earlier, he was part of the founding team at XAmplifier, serving as Managing Director for Europe for nearly a decade. According to his profile, he helped build a SaaS platform used by 2.5 million patients in the United States and established the company’s European headquarters.Deriv Moves to Single CEO StructureLast year, Deriv moved to a single Chief Executive Officer structure following changes in its top leadership, with co-founder Jean-Yves Sireau stepping back from executive management. The company appointed Rakshit Choudhary as sole CEO, ending the previous co-CEO arrangement. Sireau, who spent nearly 25 years at the firm, stepped away from day-to-day responsibilities but remains the majority shareholder and is expected to continue in a strategic capacity. He has also launched a new venture focused on AI-driven health optimisation. This article was written by Tareq Sikder at www.financemagnates.com.

Read full article on FINANCEMAGNETS